| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 3475267
[patent_doc_number] => 05428023
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-06-27
[patent_title] => 'Oral delivery of biologically active substances bound to vitamin B12 or analogues thereof'
[patent_app_type] => 1
[patent_app_number] => 8/061343
[patent_app_country] => US
[patent_app_date] => 1993-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4316
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/428/05428023.pdf
[firstpage_image] =>[orig_patent_app_number] => 061343
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/061343 | Oral delivery of biologically active substances bound to vitamin B12 or analogues thereof | May 16, 1993 | Issued |
Array
(
[id] => 3029863
[patent_doc_number] => 05349052
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-09-20
[patent_title] => 'Process for fractionating polyethylene glycol (PEG)-protein adducts and an adduct for PEG and granulocyte-macrophage colony stimulating factor'
[patent_app_type] => 1
[patent_app_number] => 8/060889
[patent_app_country] => US
[patent_app_date] => 1993-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 26
[patent_no_of_words] => 9389
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/349/05349052.pdf
[firstpage_image] =>[orig_patent_app_number] => 060889
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/060889 | Process for fractionating polyethylene glycol (PEG)-protein adducts and an adduct for PEG and granulocyte-macrophage colony stimulating factor | May 11, 1993 | Issued |
| 08/058227 | ANTIGENIC PREPARATION AND ISOLATION OF SUCH PREPARATIONS | May 9, 1993 | Pending |
Array
(
[id] => 3426725
[patent_doc_number] => 05422425
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-06-06
[patent_title] => 'Methods for the identification of cytokine convertase inhibitors'
[patent_app_type] => 1
[patent_app_number] => 8/053558
[patent_app_country] => US
[patent_app_date] => 1993-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 6491
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/422/05422425.pdf
[firstpage_image] =>[orig_patent_app_number] => 053558
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/053558 | Methods for the identification of cytokine convertase inhibitors | Apr 25, 1993 | Issued |
| 08/049481 | IDENTIFICATION OF CELL DENSITY SIGNAL MOLECULE | Apr 18, 1993 | Pending |
Array
(
[id] => 3447097
[patent_doc_number] => 05420250
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-05-30
[patent_title] => 'Phase transfer process for producing native plasma protein concentrates'
[patent_app_type] => 1
[patent_app_number] => 8/044585
[patent_app_country] => US
[patent_app_date] => 1993-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14973
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/420/05420250.pdf
[firstpage_image] =>[orig_patent_app_number] => 044585
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/044585 | Phase transfer process for producing native plasma protein concentrates | Apr 7, 1993 | Issued |
Array
(
[id] => 2989481
[patent_doc_number] => 05366717
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-11-22
[patent_title] => 'Method for producing elemental sulfur from sulfur-containing gases'
[patent_app_type] => 1
[patent_app_number] => 8/040077
[patent_app_country] => US
[patent_app_date] => 1993-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4147
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/366/05366717.pdf
[firstpage_image] =>[orig_patent_app_number] => 040077
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/040077 | Method for producing elemental sulfur from sulfur-containing gases | Mar 29, 1993 | Issued |
Array
(
[id] => 4176669
[patent_doc_number] => 06084072
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-07-04
[patent_title] => 'Purified lectin and methods of use'
[patent_app_type] => 1
[patent_app_number] => 8/041287
[patent_app_country] => US
[patent_app_date] => 1993-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 15197
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/084/06084072.pdf
[firstpage_image] =>[orig_patent_app_number] => 041287
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/041287 | Purified lectin and methods of use | Mar 29, 1993 | Issued |
Array
(
[id] => 3007123
[patent_doc_number] => 05374715
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-12-20
[patent_title] => 'Method for forming proteoliposome and method for forming giant proteoliposome'
[patent_app_type] => 1
[patent_app_number] => 8/032632
[patent_app_country] => US
[patent_app_date] => 1993-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 7
[patent_no_of_words] => 8965
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/374/05374715.pdf
[firstpage_image] =>[orig_patent_app_number] => 032632
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/032632 | Method for forming proteoliposome and method for forming giant proteoliposome | Mar 16, 1993 | Issued |
| 08/025216 | COMPOSITIONS AND METHODS FOR TREATING WOUNDS | Mar 1, 1993 | Abandoned |
Array
(
[id] => 3522701
[patent_doc_number] => 05540919
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-07-30
[patent_title] => 'Method for enhancement of production of lymphokines and applications thereof'
[patent_app_type] => 1
[patent_app_number] => 8/018471
[patent_app_country] => US
[patent_app_date] => 1993-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 15
[patent_no_of_words] => 6056
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/540/05540919.pdf
[firstpage_image] =>[orig_patent_app_number] => 018471
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/018471 | Method for enhancement of production of lymphokines and applications thereof | Feb 15, 1993 | Issued |
Array
(
[id] => 3830467
[patent_doc_number] => 05760183
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-02
[patent_title] => 'Process for the manufacture of very high-purity antithaemophilic factor (FVIIIc), and von Willebrand factor, and pharmaceutical compositions containing same'
[patent_app_type] => 1
[patent_app_number] => 8/016807
[patent_app_country] => US
[patent_app_date] => 1993-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6364
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 316
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/760/05760183.pdf
[firstpage_image] =>[orig_patent_app_number] => 016807
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/016807 | Process for the manufacture of very high-purity antithaemophilic factor (FVIIIc), and von Willebrand factor, and pharmaceutical compositions containing same | Feb 10, 1993 | Issued |
Array
(
[id] => 3525113
[patent_doc_number] => 05504069
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-04-02
[patent_title] => 'Inhibition of trauma-induced tumor growth'
[patent_app_type] => 1
[patent_app_number] => 8/016720
[patent_app_country] => US
[patent_app_date] => 1993-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7974
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/504/05504069.pdf
[firstpage_image] =>[orig_patent_app_number] => 016720
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/016720 | Inhibition of trauma-induced tumor growth | Feb 10, 1993 | Issued |
Array
(
[id] => 3458463
[patent_doc_number] => 05401833
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-03-28
[patent_title] => 'Method and apparatus for treating chrome leather waste'
[patent_app_type] => 1
[patent_app_number] => 8/012003
[patent_app_country] => US
[patent_app_date] => 1993-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 3925
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/401/05401833.pdf
[firstpage_image] =>[orig_patent_app_number] => 012003
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/012003 | Method and apparatus for treating chrome leather waste | Jan 31, 1993 | Issued |
Array
(
[id] => 3418043
[patent_doc_number] => 05434139
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-07-18
[patent_title] => 'Detection of heparin-binding seminal plasma proteins'
[patent_app_type] => 1
[patent_app_number] => 8/005869
[patent_app_country] => US
[patent_app_date] => 1993-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 18
[patent_no_of_words] => 11489
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/434/05434139.pdf
[firstpage_image] =>[orig_patent_app_number] => 005869
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/005869 | Detection of heparin-binding seminal plasma proteins | Jan 14, 1993 | Issued |
| 07/997113 | SCAVENGER RECEPTOR PROTEIN AND ANTIBODY THERETO | Dec 23, 1992 | Abandoned |
Array
(
[id] => 3654953
[patent_doc_number] => 05658714
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-08-19
[patent_title] => 'Isolation of proteins by ultrafiltration'
[patent_app_type] => 1
[patent_app_number] => 7/997616
[patent_app_country] => US
[patent_app_date] => 1992-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8496
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 283
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/658/05658714.pdf
[firstpage_image] =>[orig_patent_app_number] => 997616
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/997616 | Isolation of proteins by ultrafiltration | Dec 22, 1992 | Issued |
| 07/991137 | COLLAGEN-BASED SORBENT POLYMER AND METHOD OF PREPARING SAME | Dec 15, 1992 | Abandoned |
Array
(
[id] => 3010742
[patent_doc_number] => 05276138
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-01-04
[patent_title] => 'Process for solubilizing animal hair'
[patent_app_type] => 1
[patent_app_number] => 7/993522
[patent_app_country] => US
[patent_app_date] => 1992-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3818
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/276/05276138.pdf
[firstpage_image] =>[orig_patent_app_number] => 993522
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/993522 | Process for solubilizing animal hair | Dec 15, 1992 | Issued |
Array
(
[id] => 4190010
[patent_doc_number] => 06153589
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-11-28
[patent_title] => '2,3-epoxy alcohols, acids and derivatives as anti retroviral chemotherapeutic agents'
[patent_app_type] => 1
[patent_app_number] => 7/991251
[patent_app_country] => US
[patent_app_date] => 1992-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13986
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/153/06153589.pdf
[firstpage_image] =>[orig_patent_app_number] => 991251
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/991251 | 2,3-epoxy alcohols, acids and derivatives as anti retroviral chemotherapeutic agents | Dec 14, 1992 | Issued |